Paper79764
Low mortality in burned patients in a Pseudomonas vaccine trial.
Jones RJ and 2 others. Lancet, 1978. Cited by 42 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Low mortality in burned patients in a Pseudomonas vaccine trial. Papers, record 79764. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/79764
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacterial Vaccines | Major topic |
| Burns | Major topic |
| Pseudomonas Infections | Major topic |
| Pseudomonas aeruginosa | Major topic |
| Wound Infection | Major topic |
| Adolescent | |
| Adult | |
| Child | |
| Child, Preschool | |
| Clinical Trials as Topic | |
| Humans | |
| Infant | |
| Middle Aged |
Source PubMed
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 29,547,971 | Potential targets for next generation antimicrobial glycoconjugate vaccines. | FEMS Microbiol Rev | 2018 | https://conductscience.org/library/papers/29547971 | PubMed |
| 21,941,090 | Recent developments for Pseudomonas vaccines. | Hum Vaccin | 2011 | https://conductscience.org/library/papers/21941090 | PubMed |
| 17,466,590 | Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity. | Int J Med Microbiol | 2007 | https://conductscience.org/library/papers/17466590 | PubMed |
| 7,520,416 | Immunogenic and antigenic properties of a heptavalent high-molecular-weight O-polysaccharide vaccine derived from Pseudomonas aeruginosa. | Infect Immun | 1994 | https://conductscience.org/library/papers/7520416 | PubMed |
| 6,783,532 | Polyvalent antisera to Pseudomonas ribosomal vaccines: protection of mice against clinically isolated strains. | Infect Immun | 1980 | https://conductscience.org/library/papers/6783532 | PubMed |
| 6,404,823 | Protective immunization against chronic Pseudomonas aeruginosa pulmonary infection in rats. | Infect Immun | 1983 | https://conductscience.org/library/papers/6404823 | PubMed |
| 3,909,641 | Nosocomial pneumonia in patients in intensive care units. | West J Med | 1985 | https://conductscience.org/library/papers/3909641 | PubMed |
| 3,513,451 | New developments in the treatment of gram-negative bacteremia. | West J Med | 1986 | https://conductscience.org/library/papers/3513451 | PubMed |
| 444,418 | The NBT test in burned patients. | Br J Exp Pathol | 1979 | https://conductscience.org/library/papers/444418 | PubMed |
| 386,890 | McIndoe lecture, 1978. Burns: McIndoe's contribution and subsequent advances. | Ann R Coll Surg Engl | 1979 | https://conductscience.org/library/papers/386890 | PubMed |
| 110,875 | Measurement of endotoxins with the limulus test in burned patients. | J Hyg (Lond) | 1979 | https://conductscience.org/library/papers/110875 | PubMed |
| 109,501 | Antibody responses of burned patients immunized with a polyvalent Pseudomonas vaccine. | J Hyg (Lond) | 1979 | https://conductscience.org/library/papers/109501 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/79764
GET https://conductscience.org/api/papers/v1/79764/authors